Universal WBC reduction.
Robert L. Thurer,Naomi L.C. Luban,James P. AuBuchon,Herbert Silver,Leo J. McCarthy,Sunny Dzik,Christopher P. Stowell,S. Breanndan Moore,Eleftherios C. Vamvakas,Will Armstrong,Michael H. Kanter,Elaine Jeter,Joanne Becker,Martha J. Higgins,Susan A. Galel,Steven Kleinman,Carol S. Marshall,Richard S. Newman,Jose A. Ocariz,Douglas P. Blackall,Lawrence D. Petz,Pearl Toy,Harold A. Oberman,Don L. Siegel,Thomas H. Price,Sherrill J. Slichter,Terry B. Gernsheimer,Paul D. Mintz,Lawrence T. Goodnough,Edward H. Lipford,Marcus B. Simpson +30 more
60
About: This article is published in Transfusion. The article was published on 01 Jun 2000. and is currently open access.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions
Paul C. Hébert,Dean Fergusson,Morris A. Blajchman,George A. Wells,Andrew Kmetic,Doug Coyle,Nancy M. Heddle,Marc Germain,Mindy Goldman,Baldwin Toye,Irwin Schweitzer,Carl vanWalraven,Dana V. Devine,Graham D. Sher +13 more
TL;DR: A national universal leukoreduction program is potentially associated with decreased mortality as well as decreased fever episodes and antibiotic use after red blood cell transfusion in high-risk patients.
412
Estimating the cost of blood: past, present, and future directions.
TL;DR: New approaches have been initiated to identify all potential cost elements related to blood and blood product administration and activities are under way to tie these elements together in a comprehensive and practical model that will be applicable to all single-donor blood products without regard to practice type.
261
Prevention of transfusion-transmitted infections.
TL;DR: A unified approach to TTIs is needed, whereby novel tests and PRTs replace, rather than add to, existing interventions, thereby ameliorating cost and logistical burden to blood centers and hospitals.
260
Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants
Haresh Kirpalani,Edward F. Bell,Susan R. Hintz,Sylvia Tan,Barbara Schmidt,Aasma S. Chaudhary,Karen J. Johnson,Margaret M. Crawford,Jamie E. Newman,Betty R. Vohr,Waldemar A. Carlo,Carl T. D'Angio,Kathleen A. Kennedy,Robin K. Ohls,Brenda B. Poindexter,Kurt Schibler,Robin K. Whyte,John A. Widness,John A.F. Zupancic,Myra H. Wyckoff,William E. Truog,Michele C. Walsh,Valerie Y. Chock,Abbot R. Laptook,Gregory M. Sokol,Bradley A. Yoder,Ravi Mangal Patel,C. Michael Cotten,Melissa F Carmen,Uday Devaskar,Sanjay Chawla,Ruth Seabrook,Rosemary D. Higgins,Abhik Das +33 more
TL;DR: In this paper, higher hemoglobin thresholds for red-cell transfusions may reduce the risk of cognitive delay among extremely low-birth-weight infants with anemia, which may be related to our work.
178
A prospective, randomized clinical trial of universal WBC reduction.
Walter H. Dzik,J.K. Anderson,E.M. O'Neill,Susan F. Assmann,Leslie A. Kalish,Christopher P. Stowell +5 more
TL;DR: Recipient exposure to allogeneic donor WBCs results in transfusion complications for selected populations of recipients, and whether or not WBC reduction should be universally applied is highly controversial.
148
References
Related Papers (5)
Raleigh A. Bowden,Sherrill J. Slichter,Sherrill J. Slichter,Sherrill J. Slichter,Merlin Sayers,Merlin Sayers,Merlin Sayers,Daniel J. Weisdorf,Daniel J. Weisdorf,Daniel J. Weisdorf,Monica Cays,Monica Cays,Monica Cays,Gary Schoch,Gary Schoch,Gary Schoch,Meera Banaji,Meera Banaji,Meera Banaji,Robert Haake,Robert Haake,Robert Haake,Kevin Welk,Kevin Welk,Kevin Welk,Lloyd Fisher,Lloyd Fisher,Lloyd Fisher,Jeffrey McCullough,Jeffrey McCullough,Jeffrey McCullough,Wesley J. Miller,Wesley J. Miller,Wesley J. Miller +33 more